Research programme: dopamine D3/D4 receptor antagonists - Korea Institute of Science and Technology
Alternative Names: dopamine D3/D4 receptor antagonists research programme - Korea Institute of Science and TechnologyLatest Information Update: 05 Jan 2004
At a glance
- Originator Korea Institute of Science and Technology
- Class
- Mechanism of Action Dopamine D3 receptor antagonists; Dopamine D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 05 Jan 2004 No development reported - Preclinical for Schizophrenia in South Korea (unspecified route)
- 20 Sep 2001 New profile
- 20 Sep 2001 Preclinical development for Schizophrenia in South Korea (Unknown route)